20670740

Source:http://linkedlifedata.com/resource/pubmed/id/20670740

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0023981, umls-concept:C0206034, umls-concept:C0242383, umls-concept:C0796392, umls-concept:C1274040, umls-concept:C1566537
pubmed:issue	2
pubmed:dateCreated	2010-7-30
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/20670740-19800611
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0370500
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A, http://linkedlifedata.com/resource/pubmed/chemical/bevacizumab, http://linkedlifedata.com/resource/pubmed/chemical/ranibizumab
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1879-1891
pubmed:author	pubmed-author:DonahueSean PSP, pubmed-author:RecchiaFrancoF, pubmed-author:SternbergPaulPJr
pubmed:issnType	Electronic
pubmed:volume	150
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	287; author reply 287
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:20670740-Angiogenesis Inhibitors, pubmed-meshheading:20670740-Antibodies, Monoclonal, pubmed-meshheading:20670740-Antibodies, Monoclonal, Humanized, pubmed-meshheading:20670740-Double-Blind Method, pubmed-meshheading:20670740-Hospitals, Veterans, pubmed-meshheading:20670740-Humans, pubmed-meshheading:20670740-Injections, pubmed-meshheading:20670740-Randomized Controlled Trials as Topic, pubmed-meshheading:20670740-Research Design, pubmed-meshheading:20670740-Retina, pubmed-meshheading:20670740-Tomography, Optical Coherence, pubmed-meshheading:20670740-Treatment Outcome, pubmed-meshheading:20670740-Vascular Endothelial Growth Factor A, pubmed-meshheading:20670740-Visual Acuity, pubmed-meshheading:20670740-Vitreous Body, pubmed-meshheading:20670740-Wet Macular Degeneration
pubmed:year	2010
pubmed:articleTitle	Bevacizumab vs ranibizumab for age-related macular degeneration: early results of a prospective double-masked, randomized clinical trial.
pubmed:publicationType	Letter, Comparative Study, Comment